Search
ABT-199: Novel Bcl-2 specific inhibitor updated results confirm substantial activity and durable responses in high-risk CLL.
Chronic Lymphocytic Leukaemia (CLL) is the most common leukemia in adults in the Western world and is diagnosed in approximately 5 persons per 100,000 population per year.
Read moreGood Governance Committee
Current committee members
Wim Fibbe, Netherlands (Chair)
Laurent Degos, France
Jean-Luc Harousseau, France
Cristina Mecucci, Italy
Helen Papadaki, Greece
Irene Roberts, United Kingdom
Pieter Sonneveld, Netherlands
AimThe Good Governance Committee (GGC) is responsible for guarding EHA’s image, position and performance as a non-profit membership organization for the public…
The EHA Guidelines Workshop, a meaningful and successful first Series!
November 2020 – April 2021
In the past six months, hematologists, clinicians, transfusion medicine specialists, oncologists, special nurses and researchers gathered virtually for the first EHA Guidelines Workshop series.
EHA-JSH Travel Grant
Financial support to help EHA members under 40 attend the Japanese Society of Hematology's Annual Meeting in October 2024.
Read more